Daniel Ansari
11 – 20 of 126
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Histological variants of pancreatic ductal adenocarcinoma : a survival analysis
(
- Contribution to journal › Article
- 2023
-
Mark
Model-based screening for pancreatic cancer in Sweden
(
- Contribution to journal › Article
-
Mark
Histopathological investigation of colon liver metastases–which factors affect survival after surgery?
(
- Contribution to journal › Article
- 2022
-
Mark
Surgical resection of pancreatic cancer with synchronous hepatic oligometastases : Real benefit or selection bias?
(
- Contribution to journal › Letter
-
Mark
Thrombospondin-2 as a diagnostic biomarker for distal cholangiocarcinoma and pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Pancreatic cancer–the past, the present, and the future
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Macropinocytosis : the Achilles’ heel of pancreatic cancer?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Organoid technology for personalized pancreatic cancer therapy
(
- Contribution to journal › Scientific review
-
Mark
Projected economic burden of pancreatic cancer in Sweden in 2030
(
- Contribution to journal › Article
-
Mark
Artificial neural networks versus LASSO regression for the prediction of long-term survival after surgery for invasive IPMN of the pancreas
(
- Contribution to journal › Article